Sally Choe, Ph.D., serves as Director of the Office of Generic Drugs (OGD) in the Center for Drug Evaluation and Research.

Jeff Francer is Interim CEO and General Counsel of the Association for Accessible Medicines, where he leads legal and international trade advocacy.

Dr. Hahn is a physician, scientist and health care leader with an extensive background in patient care, academic research and executive leadership.

Doug Long is Vice President of Industry Relations at QuintilesIMS (now IQVIA), the world’s largest pharmaceutical information company. IQVIA offers services to the pharmaceutical industry in over 101 countries around the globe.

Administrator Verma has set a bold agenda that emphasizes delivering value to patients, while also stressing greater quality and safety in America’s health care. Knowing what CMS is planning is essential to your own business strategy.

Alok is a Global Leader in the Pharmaceuticals and Health Care industry with a proven track record and nearly 25 years of industry experience.

Chris Wallace breaks down today’s top news issues impacting individuals and industry, leaving audiences with takeaways that prepare them for impending changes in the political landscape.

Janet Woodcock is Director of the Center for Drug Evaluation and Research (CDER), at the Food and Drug Administration (FDA).